Current position

Millennium Management LLC’s Boston Scientific Corp (BSX) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Millennium Management LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2021Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares11.36MHighest verified quarter-end share count
Quarters reported20Verified quarters with shares above zero
What happened?

Millennium Management LLC first reported Boston Scientific Corp in Q3 2021. The reported position was increased and reduced across later filings. Millennium Management LLC currently reports 5.44M shares. The latest verified filing showed: Bought 25.4% more.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Bought 25.4% more+1.10M shares · 5.44M shares reported after the change
Filing context

Quarter-end price $38.76

Q1 2026
Sold 61.5% of the position−6.93M shares · 4.34M shares remained
Filing context

Quarter-end price $55.52

Q4 2025
Bought 32.1% more+2.74M shares · 11.26M shares reported after the change
Filing context

Quarter-end price $91.12

Q3 2025
Bought 83.9% more+3.89M shares · 8.52M shares reported after the change
Filing context

Quarter-end price $91.90

Q2 2025
Sold 44.4% of the position−3.71M shares · 4.64M shares remained
Filing context

Quarter-end price $95.83

Q1 2025
Sold 8.6% of the position−784.57K shares · 8.34M shares remained
Filing context

Quarter-end price $94.84

Portfolio importance

How important is Boston Scientific Corp in Millennium Management LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.1%Q2 2026
Current rank#226of 5796 reported positions
Peak portfolio weight0.4%Q4 2025
Best historical rank#24Q1 2023
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$44.922026-09-22

Market context only; not an investor transaction price.

Latest filing quarter-end price$38.76Q2 2026

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This is a bounded selection from a 13F combination report. A portion is reported separately by another manager. The profile does not represent all investments, trades or performance. Quarters are reporting observations, not transaction dates.